ENvue Medical, Inc.
FEED· OTC
Released Apr 15, 2021, after the close
10-K filed Apr 15, 2021, 105 days after period end · 0001493152-21-008951
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures |
|---|---|---|---|---|
| Revenue | $90.00K | $87.00K | $55.00K | $70.00K |
| Net Income | -$1.01M | -$1.19M |
ENvue Medical, Inc. · CIK 1326706 · Engraved from SEC EDGAR
| -$1.20M |
| -$1.64M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.